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ABSTRACT
While investigating the differentiation potential of bone
marrow-derived cells, we previously demonstrated upre-
gulated expression of the lung-related surfactant protein
B (SP-B) gene in hematopoietic progenitor cells (HPCs)
when they were cocultured with macerated lung tissue.
During coculture, HPCs differentiated toward a dendri-
tic-like myeloid cell phenotype (hematopoietic progenitor
cell-derived dendritic-like cells [HPC-DCs]). However,
immature dendritic cells (iDCs) cocultured under identi-
cal conditions did not express SP-B mRNA before or af-
ter coculture. We have now further examined the
regulation of SP-B expression in HPC-DCs and iDCs. Of
the transcription factors involved in SP-B gene expres-
sion, neither cell type expressed TTF-1, HNF3a, or
HNF3b, but both cell types expressed Sp1 and Sp3. Sp1
binding to the SP-B promoter was investigated in these
cells. Three novel Sp1 binding motifs were identified in
the mouse SP-B promoter. Using chromatin immunopre-
cipitation, it was demonstrated that Sp1 was bound to all
three sites in HPC-DCs after coculture with lung tissue,
but not in iDCs. We hypothesized that although genes
from multiple lineages may be active in HPCs, gene
silencing events, such as methylation, may subsequently
occur to suppress expression of these genes in more
mature myeloid cells, such as iDCs. Treatment with the
demethylating agent 5-azacytidine resulted in expression
of the SP-B gene in iDCs. These data indicate that tissue-
specific transcription factors are not required to express
the lung-related gene SP-B in hematopoietic progenitor
cells. Furthermore, silencing events, such as methylation,
may occur to suppress lung-related gene expression as
progenitor cells become committed toward more mature
hematopoietic cell phenotypes. STEM CELLS 2009;27:662–
669
Disclosure of potential conflicts of interest is found at the end of this article.
INTRODUCTION
Reports that bone marrow (BM)-derived cells can engraft in
vivo in lungs and differentiate into lung epithelial cells
remain controversial (reviewed in [1]). Most studies have
involved delivery of donor BM-derived cells to recipient mice
that have some form of lung injury. Subsequent apparent
coexpression of donor markers, such as the Y chromosome or
green fluorescent protein, with lung epithelial cell markers,
usually cytokeratins or surfactant proteins, is proposed to rep-
resent differentiation of BM-derived cells into lung epithelial
cells. However, difficulties associated with several of these in
vivo studies include verification that lung epithelial cells arose
from BM-derived cells, identification of the specific type(s) of
BM-derived cell that engrafts, and whether differentiation or
fusion is occurring.
To address some of these issues, we previously reported
an in vitro coculture system in which BM-derived cells are
physically separated from mechanically macerated lung tissue
obtained from otherwise healthy animals [2]. We hypothe-
sized that if differentiation of BM-derived cells is occurring
in injured lungs in vivo, it is likely that soluble lung-derived
factors, such as those released from disrupted lung cells and
extracellular matrices during maceration, are involved. We
therefore examined the ability of hematopoietic progenitor
cells (HPCs) to express lung-related genes in response to
these soluble factors. When HPCs were cocultured with
macerated lung tissue, upregulation of surfactant protein B
(SP-B), cytokeratin 7, and cytokeratin 18 gene expression
occurred, indicating that soluble lung-derived factors can
upregulate lung-related gene expression in BM-derived cells
in the absence of fusion [2]. The HPCs differentiated toward
a dendritic cell-like population (hematopoietic progenitor cell-
derived dendritic-like cells [HPC-DCs]) during coculture.
However, when immature dendritic cells (iDCs) were first
derived in vitro from cultured BM and subsequently placed in
coculture with lung tissue, no expression of lung-related genes
was detected either before or after culture. We concluded that
lung-related gene expression was permissible only in more
immature myeloid precursor cells under these coculture
conditions.
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The long-standing paradigm of stem cell differentiation pro-
poses that lineage-specific genes are inactive in stem cells and
progenitor cells and are subsequently induced during tissue-spe-
cific differentiation. However, a new concept for the process of
stem cell differentiation has been emerging in recent years. It
has been suggested that stem cells in fact express a wide range
of genes characteristic of the multiple lineage paths that these
cells may be capable of adopting and that specific genes are
silenced as cells progress along a particular differentiation path-
way [3]. In support of this theory are reports describing expres-
sion of multilineage genes within progenitor cells. Isolated sin-
gle bone marrow stromal cells, for example, simultaneously
express transcripts characteristic of epithelial, endothelial, osteo-
blast, fibroblast, muscle, and neural/glial cells [4].
We were interested in whether a similar process occurs in
bone marrow-derived HPCs and so examined mechanisms
underlying regulation of expression of the lung-related SP-B
gene in progenitor cells (HPC-DCs) and more mature cells
(iDCs) in our lung coculture system. Despite their similar
dendritic cell (DC)-like phenotypes following coculture, SP-B
mRNA expression was detected only in HPCs following co-
culture with macerated lung tissue, and not in iDCs. We
examined expression of transcription factors known to induce
SP-B gene expression but found no difference in transcription
factor profile that would explain SP-B gene expression in
HPC-DCs and its absence from iDCs. We therefore hypothe-
sized that although SP-B gene expression was permissible in
HPCs, gene silencing events in more mature myeloid cells,
such as iDCs, could prevent expression of SP-B in these cells.
Gene silencing occurs when DNA is packaged around histo-
nes into nucleosomes. Modifications of histone proteins and
DNA, including phosphorylation, methylation, and acetyla-
tion, alter DNA-histone interactions, thereby governing DNA-
transcription factor interactions.
In the present study, we identified three previously unde-
scribed putative Sp1 binding motifs in the mouse SP-B pro-
moter and used chromatin immunoprecipitation to examine
Sp1 binding to these motifs. We then used the demethylating
agent 5-azacytidine to determine whether methylation was a
potential mechanism of silencing SP-B gene expression in
iDCs. Our data indicate that Sp1 activity is sufficient for
expression of the SP-B gene in HPC-DCs and that methyla-
tion suppresses expression of SP-B in more mature iDCs.
MATERIALS AND METHODS
Coculture of Hematopoietic Progenitor Cells
Bone marrow cells were isolated from 6-8-week-old female C3H-
Hen mice (Harlan, Bicester, U.K., http://www.harlan.com). Care of
animals was in accordance with institutional guidelines. Following
cervical dislocation, whole bone marrow was obtained by flushing
the femurs and tibias with an ice-cold solution of phosphate-buf-
fered saline with 0.5% bovine serum albumin and 2 mM EDTA
(Sigma-Aldrich, Dublin, Ireland, http://www.sigmaaldrich.com).
Red blood cells were lysed using an RBC Lysis Solution (BioLe-
gend, San Diego, http://www.biolegend.com). A cell population
enriched for HPCs was obtained from the remaining cell suspension
using a lineage depletion-negative selection kit according to the
manufacturer’s instructions (R&D Systems Inc., Abingdon, U.K.,
http://www.rndsystems.com). Mature lineage-positive cells were
depleted magnetically using antibodies to CD5, CD11b, CD45R,
Ly-6G, and Ter119. Cocultures were set up in a complete bone
marrow medium consisting of RPMI 1640 supplemented with
13.5% (vol/vol) heat-inactivated fetal bovine serum (Gibco, Poole,
U.K., http://www.invitrogen.com), 2 mM L-glutamine (Gibco), 5
ng/ml (wt/vol) gentamicin (Sigma-Aldrich), and 10% (vol/vol) con-
ditioned media from Giant Cell Tumor (Sigma-Aldrich). Four
grams (weight wet) of lung tissue was placed in 6 ml of complete
bone marrow medium and minced to approximately 1-mm3 cubes.
Eight hundred microliters of medium only or tissue suspension was
placed in each well, and the insert was added. A 330-ll cell sus-
pension enriched for HPCs containing 5  105 cells per milliliter
was added to the insert. Cocultures were maintained at 37C in a
humidified atmosphere with 5% CO2.
Culture of Immature Dendritic Cells
Whole bone marrow was obtained by flushing the femurs and
tibias of 6-8-week-old female C3H-Hen mice with a warm solu-
tion of RPMI-1640 (Sigma-Aldrich) containing 1% (vol/vol) Pen-
icillin-Streptomycin (Gibco). Dendritic cells were cultured as pre-
viously described with minor modifications (cells were harvested
from the suspension at day 7) [5]. Briefly, bone marrow cells
were cultured in complete medium supplemented with 150 lg/ml
granulocyte macrophage-colony-stimulating factor (GM-CSF).
After 3 days, suspension cells were discarded, and fresh medium
was added to the adherent cells. After a further 4 days, iDCs
were harvested as nonadherent cells from the medium. Cells were
cocultured as described above but in six-well inserts in complete
medium supplemented with 150 lg/ml GM-CSF. One milliliter of
cell suspension was seeded into six-well tissue culture plate
inserts. Inserts were placed into six-well plates containing 2 ml of
control medium or lung tissue suspension per well.
Characterization of Cells by Flow Cytometry
The following antibodies were used to characterize cells: CD11b-
phycoerythrin (PE), CD11c-fluorescein isothiocyanate (FITC), F4/
80-FITC, and major histocompatibility factor (MHC)-II-PE (eBio-
science Inc., San Diego, http://www.ebioscience.com). Appropri-
ate isotype control antibodies were used (eBioscience). Cells (1
 105) were incubated with 0.5 ll of antibody for 10 minutes at
4C. Cells were washed, and flow cytometry was performed using
a FACSCalibur instrument (Becton, Dickinson and Company,
Cowley, U.K., http://www.bd.com) and analyzed using CellQuest
software (Becton Dickinson).
Reverse Transcription-Polymerase Chain Reaction
Total RNA was extracted from cells using TriZol (Invitrogen, Pais-
ley, U.K., http://www.invitrogen.com) according to the manufac-
turer’s instructions. Samples were treated with DNase I, Amp Grade
(Invitrogen), for 25 minutes, and cDNA was synthesized using
Moloney murine leukemia virus Reverse Transcriptase (Invitrogen).
Polymerase chain reaction (PCR) primers were designed using
Primer 30 web software (Whitehead Institute for Biomedical
Research, Cambridge, Massachusetts, http://www.wi.mit.edu). PCR
consisted of 35 cycles: 94C for 45 seconds (denaturation), 55C–
58C for 45 seconds (annealing), and 72C for 1 minute (extension)
using a PTC-100 programmable thermal cycler (MJ Research, Inc.,
Quebec, Canada, http://www.mj-research.com). Murine airway epi-
thelial cells, isolated as previously described [6], were used as a
positive control. PCR primers are listed in Table 1.
Western Blotting
Approximately 4  106 cells were lysed in 30 ll of RIPA buffer
(150 mM NaCl, 1% Nonidet P40, 0.5% sodium deoxycholate, 0.1%
SDS, 50 mM Tris) supplemented with 1 Complete Mini protease
inhibitor cocktail (Roche, Dublin, Ireland, http://www.roche-
applied-science.com). Fifteen micrograms of protein was electro-
phoresed on 12% SDS-polyacrylamide gel electrophoresis gels and
blotted onto nitrocellulose membrane. Blots were probed with glyc-
eraldehyde-3-phosphate dehydrogenase (Millipore, Carrigtwohill,
Ireland, http://www.millipore.com), Sp1 (Active Motif, Rixenhart,
Belgium), and Sp3 (Santa Cruz Biotechnology Inc., Santa Cruz,
CA, http://www.scbt.com) primary antibodies followed by the
appropriate horseradish peroxidase-conjugated secondary antibody.
Immunoreactivity was visualized by chemiluminescence.
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Chromatin Immunoprecipitation
Chromatin immunoprecipitation was carried out using approxi-
mately 6  106 cells using the ChipIT-Express kit according to
the manufacturer’s instructions (Active Motif, Rixensart, Bel-
gium, http://www.activemotif.com). PCR consisted of 36 cycles:
94C for 30 seconds, 56C–58C for 20 seconds, and 72C for
20 seconds. Chromatin immunoprecipitation (ChIP) primers are
listed in Table 1.
Culture with 5-Azacytidine
At day 3 of the 7-day culture to derive iDCs, 5-azacytidine (5-aza)
(Sigma-Aldrich) was added to a final concentration of 40 lM and
was replaced with fresh medium 24 hours later. Cell numbers and
viability were monitored by ethidium bromide/acridine orange stain-
ing (Sigma-Aldrich). On day 7, iDCs were harvested and placed in
coculture with lung tissue as described above.
RESULTS
Expression of SP-B and SP-B-Related Transcription
Factors in HPC-DCs and iDCs After Coculture with
Lung Tissue
We previously characterized HPCs to be lin[] c-Kitþ CD34lo
Sca1lo [2]. When these HPCs are exposed to soluble signals
from macerated lung tissue, they differentiate toward a DC-
like phenotype, HPC-DC, that expresses increased levels of
SP-B mRNA compared with either freshly isolated HPCs or
HPCs cultured with control medium. It is possible that these
lung-derived soluble signals are capable of upregulating SP-B
gene expression only in HPCs that subsequently differentiate
into DC-like cells that then retain these higher levels of SP-B
mRNA. Alternatively, upregulation of SP-B gene expression
may occur after HPCs begin to differentiate toward DCs. To
explore these possibilities, we generated iDCs in vitro and
then examined their ability to upregulate SP-B gene expres-
sion when cocultured with macerated lung tissue. iDCs were
first derived by culturing bone marrow cells in the presence
of GM-CSF for 7 days and subsequently cocultured with lung
tissue for 3 days. HPC-DCs were derived by culturing HPCs
with lung tissue for 3 days. The resulting iDC and HPC-DC
cell phenotypes were compared.
The HPC-DC population was phenotypically similar to
iDCs after coculture (Fig. 1). Both populations were CD11bhi,
although iDCs expressed more CD11c and F4/80. The iDC
population was more uniform in its expression of CD11c,
although the HPC-DCs may have differentiated into a more
mixed myeloid population. HPC-DCs cocultured with lung
tissue expressed SP-B mRNA, whereas no SP-B mRNA was
detected in cocultured iDCs (Fig. 2A).
TTF-1, HNF3a, and HNF3b are lung-related transcription
factors that regulate expression of several lung-related genes
and are the primary factors that regulate SP-B gene expres-
sion [7–9]. Sp1 and Sp3 are ubiquitous transcription factors
that regulate a wide range of genes in most tissue types and
are also involved in transcriptional regulation of SP-B [9]. To
examine whether differences in the profiles of SP-B-related
transcription factors could explain the absence of SP-B tran-
scripts in iDCs, expression of these transcription factors was
determined in HPC-DCs and iDCs after 3 days of coculture
with lung tissue. MLE-12 mouse lung cells express SP-B and
were used for comparison.
Strong expression of all transcription factor genes was
detected in MLE-12 cells (Fig. 2A). However, neither HPC-
DCs nor iDCs expressed TTF-1, HNF3a, or HNF3b genes af-
ter coculture. Sp1 and Sp3 mRNA and protein were detected
in both HPC-DCs and iDCs (Fig. 2A, 2B). Levels of Sp1 pro-
tein were similar in HPC-DCs, iDCs, and MLE-12 cells. Sp3
protein levels were higher in iDCs compared with HPC-DCs.
Table 1. List of primers
Gene Primer TA (
C) Product (bp)
RT-PCR
GAPDH F: 50-CTGCACCACCAACTGCTTAG-30 55 487
R: 50-CCAGGAAATGAGCTTGACAAA-30
SP-B F: 50-CTACCTGCCCCTGGTTAT-30 58 549
R: 50-GACTTGCAGAAATGGCAC-30
TTF-1 F: 50-GTGCCGGTCCTAGTCAAAGA-30 58 273
R: 50-CAGATGGGATAGGCTGGAGA-30
HNF3a F: 50-CGCTTCGGAGTTGAAGTCTC-30 58 372
R: 50-AGCACGGGTCTGGAATACAC-30
HNF3b F: 50-CTCTTCCGTGAGCAACATGA-30 58 392
R: 50-TGTAGCTGCGTCGGTATGTC-30
Sp1 F: 50-TTCTCAGACTCGAAGCAGCA-30 58 346
R: 50-CACAACATACTGCCCACCAG-30
Sp3 F: 50-CTTTGACGCCTGTTCAGACA-30 55 374
R: 50-ACCTCTCCCACCACCTTCTT-30
ChIP
SP-B1 F: 50-CCACAGGGGACACAGAAATC-30 57 387
R: 50-CGATGTCGGTTCCTAGTCCT-30
SP-B2 F: 50-TGCTGGAGGACTTTCTAGGG-30 57 181
R: 50-TGAGGCTATGTCCACACCTG-30
SP-B3 F: 50-CAGTGCTCACCTGTATGTGG-30 58 208
R: 50-CCCAAGTGCTGGGATTAAAA-30
CD11b1 F: 50-TGTTTTTACCCCTCCCTCCT-30 58 189
R: 50-CAATCTGAGGACCCCCTTCT-30
CD11b2 F:-50-AGCCTGATCCGAAACACTGA-30 56 260
R: 50-AGGAGGGAGGGGTAAAAACA-30
Abbreviations: bp, base pairs; ChIP, chromatin immunoprecipitation; F, forward; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; R,
reverse; RT-PCR, reverse transcription-polymerase chain reaction; SP-B, surfactant protein B; TA, annealing temperature.
664 Regulation of SP-B Expression in BM-Derived Cells
Analysis of Sp1 Binding Sites in the Mouse SP-B
Promoter
Because neither HPC-DCs nor iDCs express the lung-related
transcription factors normally required for SP-B gene expres-
sion, we hypothesized that random Sp1 and Sp3 activity may
be responsible for inducing SP-B expression in HPCs.
Because Sp3 expression was relatively low in HPC-DCs de-
spite upregulated SP-B expression, we decided to examine
whether differences in Sp1 activity between HPC-DCs and
iDCs could explain the presence of SP-B transcripts in the
former and their absence from the latter.
Although Sp1 binding sites have previously been identi-
fied in the proximal region of both the human and rabbit SP-
B promoters [7, 9], no Sp1 sites have been described in the
mouse SP-B promoter to date. The minimal Sp1 binding
motif is 50-GCGGG-30 [10]. An alignment of the proximal
regions of the human, rabbit, and mouse SP-B promoter dem-
onstrates that the Sp1 sites identified in the rabbit promoter
are not present in the mouse promoter (Fig. 3A). We therefore
analyzed the SP-B promoter for putative Sp1 binding sites.
Deletion analysis has previously shown that the region down-
stream of 842 base pairs (bp) is important in the control of
transcription of the mouse SP-B gene [11]. Furthermore, dis-
tally bound Sp1 located up to 1.8 kilobases away can interact
with proximally bound Sp1 by looping out the intervening
DNA and acting in a synergistic manner [12, 13]. Therefore,
the region between þ1 and 2,000 bp was analyzed for Sp1
binding motifs. Three putative Sp1 sites were identified in the
mouse SP-B promoter at 336, 733, and 1,243 bp (Fig.
3B).
Chromatin Immunoprecipitation
ChIP was carried out to confirm these novel Sp1 binding sites
in the mouse SP-B gene and to examine potential differential
Sp1 activity at these sites in HPC-DCs compared with iDCs
after coculture with lung tissue. MLE-12 cells were used as a
positive technical control. PCR primers sets were designed to
span each of the three putative Sp1 sites, designated primer
sets 1, 2, and 3 (Fig. 4A). An additional two previously unre-
ported Sp1 binding motifs were identified in the CD11b pro-
moter, and primers sets were designed to span these (Fig.
4B). Sp1 binding to the CD11b promoter was used as an in-
ternal control as both HPC-DCs and iDCs express high levels
of CD11b, whereas MLE-12 cells do not. IgG control anti-
bodies were used to control for nonspecific DNA amplifica-
tion, which was subtracted from that detected with the anti-
Sp1 antibody.
DNA surrounding the three putative Sp1 sites in the SP-B
promoter was immunoprecipitated using an anti-Sp1 antibody.
Significantly higher levels of DNA were detected for all three
sites in cocultured HPC-DCs compared with iDCs, indicating
a greater degree of occupancy of these Sp1 sites in HPC-DCs
(Fig. 4C). DNA surrounding the putative Sp1 sites in the
CD11b promoter was also detected in both HPC-DCs and
iDCs, with significantly less DNA detected from the MLE-12
cells as predicted.
Demethylation of the SP-B Promoter in iDCs
Having confirmed that the three putative Sp1 sites in the SP-
B promoter were capable of binding Sp1 and that a higher
level of occupancy occurred in HPC-DCs cocultured with
macerated lung tissue compared with cocultured iDCs, we
hypothesized that methylation of the SP-B promoter may
render these Sp1 sites inaccessible in iDCs. Therefore, we
examined the effects of the demethylating agent 5-aza on SP-
B gene expression in iDCs.
5-Aza was added on day 3 of the 7-day culture period in
which bone marrow cells were cultured with GM-CSF to gen-
erate iDCs. Treatment with 5-aza resulted in a 30% decrease
in the yield of iDCs at day 7 compared with cultures that did
not receive 5-aza. However, treated cultures remained 98%
viable and were phenotypically similar to untreated iDCs, as
determined by their expression of CD11b, CD11c, F4/80, and
MHC II (data not shown). 5-Aza-treated and untreated iDCs
were subsequently cocultured with lung tissue or in medium-
only control for 3 days. SP-B gene expression was determined
by reverse transcription-PCR.
Induction of SP-B gene expression was evident in 5-aza-
treated iDCs, both in medium-only controls and in cocultures
with lung tissue (Fig. 5). Nested PCR was carried out to fur-
ther amplify the SP-B product. It was possible that 5-aza
treatment induced expression of transcription factors, which in
turn resulted in SP-B expression rather than direct demethyla-
tion of the SP-B promoter itself. Expression of TTF-1,
Figure 1. Characterization of HPC-DCs and iDCs after coculture
with macerated lung tissue. We have previously shown that HPCs dif-
ferentiate into myeloid dendritic-like cells (HPC-DCs) when cocul-
tured with lung tissue for 3 days [2]. We now show that iDCs have a
similar phenotype after 3 days in coculture with lung tissue. Graphs
are representative of three separate experiments. Abbreviations: FITC,
fluorescein isothiocyanate; HPC-DC, hematopoietic progenitor cell-
derived dendritic-like cell; iDC, immature dendritic cell.
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HNF3a, HNF3b, Sp1, and Sp3 genes was therefore also
examined. Neither untreated nor 5-aza-treated iDCs expressed
TTF-1, HNF3a, or HNF3b after coculture with lung tissue.
Untreated and 5-aza-treated iDCs expressed similar levels of
Sp1 and Sp3 genes in medium only and in cocultures with
lung tissue.
Levels of SP-B mRNA did not appear increased in iDCs
cocultured with lung tissue compared with medium-only con-
trols. Therefore, we deduced that demethylation of the SP-B
promoter was sufficient to allow transcription of SP-B in the
absence of signals from the lung tissue. We therefore exam-
ined SP-B expression in iDCs at day 7 after treatment with 5-
aza, without further coculture. Treatment with 5-aza was suffi-
cient to allow weak expression of SP-B, as shown by nested
PCR (Fig. 6A). Chromatin immunoprecipitation was carried
out to investigate Sp1 binding to the SP-B promoter regions
as before. Although to a lower degree than in HPCs, there
was increased occupancy of Sp1 at the SP-B promoter regions
in 5-aza-treated iDCs compared with untreated iDCs (Fig.
6B).
We therefore conclude that SP-B expression in 5-aza-
treated iDCs occurred, at least in part, as a result of demethy-
lation of the SP-B promoter and subsequent induction by Sp1.
This occurred in the absence of lung-specific signals.
DISCUSSION
Surfactant protein expression is widely used as a lung cell
marker in studies of bone marrow-derived cell differentiation
into lung epithelial cells in vivo. However, several issues
remain to be clarified in these studies, including establishing
the identity of the bone marrow cell type that has ultimately
engrafted into the lungs and definitive confirmation that lung
markers are expressed in these engrafted cells. We previously
examined SP-B expression in bone marrow-derived HPCs fol-
lowing exposure to soluble signals from macerated lung tissue
in coculture. Over the course of the coculture, HPCs differen-
tiated toward a dendritic-like myeloid phenotype, HPC-DC, in
which SP-B mRNA levels were increased. However, when
iDCs were cocultured with lung tissue, SP-B mRNA was not
detected before or after coculture. In that study we assessed
the possibility of crossover of cellular material or DNA-con-
taining vesicles in the coculture. Aliotta et al. [14] demon-
strated that DNA-containing vesicles can be released from
lung tissue and phagocytosed by myeloid cells. We found no
evidence of this in our coculture system [2].
In the present study, we hypothesized that upregulation of
SP-B occurs in HPC-DCs when cocultured with macerated
lung tissue because they receive appropriate signals while
they are immature progenitor cells during the culture period,
before they differentiate toward a DC-like phenotype. In con-
trast, SP-B expression is not permissible in more mature iDCs
in response to the same signals because of differences in ei-
ther transcriptional or epigenetic regulation of the SP-B gene
in these cells, or both. We therefore determined the SP-B
transcription factor profile in both cell types and examined
methylation of the SP-B promoter.
We discovered that neither HPC-DCs nor iDCs express
the lung-related transcription factors TTF-1, HNF3a, and
HNF3b, which would be expected to induce transcription of
the SP-B gene in lung cells (Fig. 2A). Sp1 and Sp3 proteins
were present in both HPC-DCs and iDCs (Fig. 2B). However,
although Sp1 protein was expressed at a similar level in both
HPC-DCs and iDCs, Sp3 protein levels were very low in
HPC-DCs. Of these two proteins, it was therefore more likely
that Sp1 was potentially involved in regulating transcription
of SP-B in HPC-DCs, and this transcription factor was exam-
ined further. No Sp1 sites have been previously described in
the mouse SP-B promoter. However, the importance of Sp1
for expression of the rabbit SP-B gene has been demonstrated
by promoter deletion analysis, whereby deletion of a single
Sp1 site decreased SP-B gene expression by 80% [9]. It has
also been shown that coexpression of Sp1 alone with the
proximal promoter region of the rabbit SP-B gene increased
CAT reporter expression significantly more than expression of
TTF-1, HNF3a, or HNF3b [15]. Expression of Sp1 alone
resulted in CAT reporter activity similar to that of combined
coexpression of Sp1, TTF-1, HNF3a, and HNF3b. Our
Figure 2. Expression of surfactant protein B (SP-B) and SP-B-related transcription factors in HPC-DCs and iDCs after coculture with macer-
ated lung tissue. (A): Reverse transcription-polymerase chain reaction HPC-DCs expressed low levels of SP-B mRNA after coculture with lung
tissue. In contrast, iDCs did not express the SP-B gene after coculture. Neither cell type expressed the lung-related transcription factors TTF-1,
HNF3a, or HNF3b genes normally required for transcription of the SP-B gene. POS and MLE both expressed high levels of the SP-B gene and
the lung-related transcription factors. Image is representative of three separate experiments. (B): Western blot. HPC-DCs cocultured with lung tis-
sue expressed low levels of Sp3 protein compared with iDCs or MLE. Cells expressed comparable levels of Sp1 protein. Image is representative
of two separate experiments. Abbreviations: bp, base pairs; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HPC-DC, hematopoietic pro-
genitor cell-derived dendritic-like cell; iDC, immature dendritic cell; MLE, MLE-12 lung cell line; NEG, control, omitting cDNA; POS, normal
primary lung epithelial cells.
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analysis revealed three novel putative Sp1 binding motifs in
the mouse SP-B promoter at 336, 733, and 1,243 bp
(Fig. 3B). Chromatin immunoprecipitation confirmed that
these are Sp1 binding sites and that Sp1 interacts with each
of these sites in HPC-DCs but not in iDCs. Ideally, epithelial
cells derived from the macerated lung tissue would have been
used as a positive control in the ChIP and demethylation
experiments in this study. However, it would be extremely
technically challenging to obtain sufficient numbers of epithe-
lial cells from macerated lung tissue for this control. There-
fore, the MLE-12 murine lung cell line was used as a positive
technical control to demonstrate binding of Sp1 to the SP-B
promoter. Sp1 interaction with the CD11b promoter was
examined as an internal control, and Sp1 was shown to be
bound to regions of the CD11b promoter containing Sp1
motifs in both HPC-DCs and iDCs after coculture (Fig. 4C).
As expected, there was little or no binding of Sp1 to the
CD11b promoter detected in MLE-12 cells, which do not
express this gene. Thus, Sp1 is bound to the SP-B promoter
in HPC-DCs exposed to signals from macerated lung tissue
and is likely to be upregulating of SP-B gene expression in
these cells. In contrast, although iDCs contain Sp1 protein,
Sp1 does not interact with the SP-B promoter in these cells in
response to signals from lung tissue.
We hypothesized that gene silencing events in more
mature committed iDCs may prevent the Sp1 transcription
factor from accessing the Sp1 sites in the promoter. Methyla-
tion of cytosine residues within promoter regions can obstruct
transcription factor binding and recruit histone deacetylases.
Several studies have suggested that methylation of adjacent
cytosines or upstream CpG dinucleotides can affect Sp1 bind-
ing [16–18].
To determine whether methylation was preventing SP-B
transcription in more mature myeloid cells, iDCs were derived
from bone marrow cells in the presence of the demethylating
agent 5-azacytidine. Treated and untreated iDCs were subse-
quently cocultured with lung tissue or in medium-only con-
trols. SP-B gene expression was detected in 5-aza-treated
iDCs both in medium-only controls and in coculture with
lung tissue (Fig. 5). Nested PCR confirmed the expression of
SP-B in 5-aza-treated iDCs. Even with these more sensitive
conditions, no SP-B mRNA was detected in untreated iDCs.
5-Aza treatment did not induce expression of TTF-1, HNF3a,
or HNF3b, and untreated and 5-aza-treated iDCs expressed
Figure 3. Analysis of Sp1 binding motifs
in the mouse surfactant protein B promoter.
(A): The TTF-1 binding sites and HNF3
binding site that make up the proximal
enhancer region of the SP-B promoter are
highly conserved in rabbit, human, and
mouse. The Sp1 binding sites in the rabbit
promoter are not present in the mouse pro-
moter. (B): Three putative Sp1 sites were
identified, at 336, 733, and 1,243
base pairs according to the minimal bind-
ing motif 50-GCGGG-30 [10].
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similar levels of Sp1 and Sp3 genes in medium only and in
cocultures with lung tissue. Therefore, the induction of SP-B
expression was not due to induced expression of transcription
factors by the demethylating agent.
5-Aza-treated iDCs expressed a similar level of SP-B
whether cultured in medium only or with macerated lung tis-
sue. It appeared that the demethylating agent was sufficient to
allow SP-B gene expression in the absence of signals from
the lung tissue. Therefore, SP-B expression was examined in
5-aza-treated iDCs at day 7 before further coculture. Weak
SP-B expression was detected (Fig. 6A). Chromatin immuno-
precipitation demonstrated increased binding of Sp1 to the
SP-B promoter region in iDCs treated with 5-aza compared
with untreated cells (Fig. 6B). This suggests that demethyla-
tion of the SP-B promoter region is sufficient to allow SP-B
expression in the absence of any lung-specific signals.
Coculture with macerated lung tissue may have resulted
in demethylation of the SP-B promoter in HPCs, allowing
Sp1 and/or Sp3 to upregulate expression of these genes. It is
possible that the same coculture conditions were not sufficient
to induce demethylation of the promoter in iDCs, whereas the
more severe treatment with 5-azacytidine resulted in demethy-
lation and subsequent Sp1/Sp3-mediated transcription.
Figure 4. Chromatin immunoprecipitation. (A): Three primer sets,
denoted by 1, 2, and 3, were designed to span the three Sp1 binding
motifs identified in the msSP-B promoter (Table 1). (B): Two primer
sets, denoted by 1 and 2, were designed to span the two Sp1 binding
motifs identified in the CD11b promoter (Table 1). (C): After 3 days
of coculture with macerated lung tissue, levels of Sp1 binding to the
DNA regions spanned by primers denoted by SP-B1, SP-B2, and SP-
B3 were higher in HPC-DCs compared with iDCs. Binding of Sp1 to
Sp1 motifs in the CD11b promoter was examined as an internal con-
trol. Levels of Sp1 binding to DNA spanned by primers denoted by
CD11b1 and CD11b2 were higher in both HPCs and iDCs after 3
days of coculture compared with MLE-12 cells. Graph represents the
mean from three separate experiments with the SD. *, p < .05; **, p
< .01; ***, p < .001; using a one-way analysis of variance and
Tukey’s post test. Abbreviations: bp, base pairs; HPC-DC, hematopoi-
etic progenitor cell-derived dendritic-like cell; iDC, immature dendri-
tic cell; SP-B, surfactant protein B.
Figure 5. Gene expression in immature dendritic cells (iDCs) after
treatment with 5-azacytidine. 5-Azacytidine induced weak expression
of SP-B both in medium-only controls and in cocultures with macer-
ated lung tissue. NSP-B confirmed expression of SP-B in 5-azacyti-
dine-treated iDCs after coculture for 3 days in medium only and in
Lu. No difference in expression of transcription factors involved in
SP-B expression was evident in 5-azacytidine-treated versus untreated
iDCs. Image is representative of two separate experiments. Abbrevia-
tions: 5-AZA, treated with 5-azacytidine; bp, base pairs; C, medium-
only control; GAPDH, glyceraldehyde-3-phosphate dehydrogenase;
Lu, coculture with lung tissue; NEG, control, omitting cDNA; NSP-B,
nested polymerase chain reaction; POS, normal primary lung epithe-
lial cells; SP-B, surfactant protein B.
Figure 6. Sp1 binding to the SP-B promoter in iDCs after treatment
with 5-azacytidine. (A): Treatment with 5-azacytidine resulted in weak
SP-B gene expression in iDCs in the absence of lung-specific signals.
Image is representative of three separate experiments. (B): Chromatin
immunoprecipitation demonstrated increased levels of Sp1 binding to
the SP-B promoter regions in iDCs after treatment with 5-azacytidine
compared with Un. Graph represents the mean from three separate
experiments with the SD. *, p < .05 using a one-way analysis of var-
iance and Tukey’s post test. Abbreviations: 5AZA, treated with 5-azacy-
tidine; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; iDC,
immature dendritic cell; NEG, control, omitting cDNA; NSP-B, nested
polymerase chain reaction; POS, normal primary lung epithelial cells;
SP-B, surfactant protein B; Un, untreated immature dendritic cell.
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SUMMARY
Our study demonstrates that HPCs are capable of expressing
the SP-B gene in the absence of lung-related transcription fac-
tors, such as TTF-1, HNF3a, or HNF3b. Our data indicate
that demethylation of the SP-B promoter leads to increased
Sp1 activity, which results in SP-B gene expression. Thus,
SP-B gene expression can be detected in these HPCs in our
coculture model system in the absence of lung-related differ-
entiation. This raises doubt as to the utility of SP-B gene
expression as a marker of lung-specific differentiation in
HPCs in vivo. However, our data also demonstrate that bone
marrow-derived cells can be reprogrammed in vitro to express
genes that are important for lung homeostasis. It is possible
that demethylation of promoter regions such as these Sp1 sites
are an early step in this reprogramming. Whether this occurs
in vivo remains to be determined.
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